0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Lyophilized Drugs Market Research Report 2024
Published Date: November 2024
|
Report Code: QYRE-Auto-22Q18430
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Lyophilized Drugs Market Research Report 2024
BUY CHAPTERS

Global Lyophilized Drugs Market Research Report 2024

Code: QYRE-Auto-22Q18430
Report
November 2024
Pages:101
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Lyophilized Drugs Market Size

The global Lyophilized Drugs market was valued at US$ 141520 million in 2023 and is anticipated to reach US$ 195920 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.

Lyophilized Drugs Market

Lyophilized Drugs Market

Lyophilized drugs are pharmaceutical products that have been freeze-dried to increase their shelf life and stability. The lyophilization process involves removing water from the drug under low temperature and pressure conditions, resulting in a dry powder form. This process preserves the drug’s effectiveness, making it ideal for medications that are sensitive to moisture and temperature. Before administration, lyophilized drugs are typically reconstituted with a sterile liquid.
North American market for Lyophilized Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Lyophilized Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Lyophilized Drugs in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Lyophilized Drugs include Roche, Amgen, AbbVie, Sanofi, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly, Novartis, Merck, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Lyophilized Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lyophilized Drugs.
The Lyophilized Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lyophilized Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lyophilized Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Lyophilized Drugs Market Report

Report Metric Details
Report Name Lyophilized Drugs Market
Accounted market size in 2023 US$ 141520 million
Forecasted market size in 2030 US$ 195920 million
CAGR 4.8%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche, Amgen, AbbVie, Sanofi, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly, Novartis, Merck, Biogen, Celltrion, Sobi, Merck & Co., Bristol Myers Squibb, GlaxoSmithKline, Takeda, AstraZeneca, Bayer, Astellas, Gilead Sciences, Teva, Boehringer Ingelheim
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Lyophilized Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Lyophilized Drugs Market growing?

Ans: The Lyophilized Drugs Market witnessing a CAGR of 4.8% during the forecast period 2024-2030.

What is the Lyophilized Drugs Market size in 2030?

Ans: The Lyophilized Drugs Market size in 2030 will be US$ 195920 million.

Who are the main players in the Lyophilized Drugs Market report?

Ans: The main players in the Lyophilized Drugs Market are Roche, Amgen, AbbVie, Sanofi, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly, Novartis, Merck, Biogen, Celltrion, Sobi, Merck & Co., Bristol Myers Squibb, GlaxoSmithKline, Takeda, AstraZeneca, Bayer, Astellas, Gilead Sciences, Teva, Boehringer Ingelheim

What are the Application segmentation covered in the Lyophilized Drugs Market report?

Ans: The Applications covered in the Lyophilized Drugs Market report are Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Others

What are the Type segmentation covered in the Lyophilized Drugs Market report?

Ans: The Types covered in the Lyophilized Drugs Market report are Single-Use Vials, Prefilled Syringes, Specialty Packaging

Recommended Reports

Lyophilization Equipment

Cold Chain Storage

Freeze Dried Pharmaceuticals

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lyophilized Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Single-Use Vials
1.2.3 Prefilled Syringes
1.2.4 Specialty Packaging
1.3 Market by Application
1.3.1 Global Lyophilized Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lyophilized Drugs Market Perspective (2019-2030)
2.2 Global Lyophilized Drugs Growth Trends by Region
2.2.1 Global Lyophilized Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Lyophilized Drugs Historic Market Size by Region (2019-2024)
2.2.3 Lyophilized Drugs Forecasted Market Size by Region (2025-2030)
2.3 Lyophilized Drugs Market Dynamics
2.3.1 Lyophilized Drugs Industry Trends
2.3.2 Lyophilized Drugs Market Drivers
2.3.3 Lyophilized Drugs Market Challenges
2.3.4 Lyophilized Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lyophilized Drugs Players by Revenue
3.1.1 Global Top Lyophilized Drugs Players by Revenue (2019-2024)
3.1.2 Global Lyophilized Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Lyophilized Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Lyophilized Drugs Revenue
3.4 Global Lyophilized Drugs Market Concentration Ratio
3.4.1 Global Lyophilized Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lyophilized Drugs Revenue in 2023
3.5 Global Key Players of Lyophilized Drugs Head office and Area Served
3.6 Global Key Players of Lyophilized Drugs, Product and Application
3.7 Global Key Players of Lyophilized Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Lyophilized Drugs Breakdown Data by Type
4.1 Global Lyophilized Drugs Historic Market Size by Type (2019-2024)
4.2 Global Lyophilized Drugs Forecasted Market Size by Type (2025-2030)
5 Lyophilized Drugs Breakdown Data by Application
5.1 Global Lyophilized Drugs Historic Market Size by Application (2019-2024)
5.2 Global Lyophilized Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Lyophilized Drugs Market Size (2019-2030)
6.2 North America Lyophilized Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Lyophilized Drugs Market Size by Country (2019-2024)
6.4 North America Lyophilized Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lyophilized Drugs Market Size (2019-2030)
7.2 Europe Lyophilized Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Lyophilized Drugs Market Size by Country (2019-2024)
7.4 Europe Lyophilized Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lyophilized Drugs Market Size (2019-2030)
8.2 Asia-Pacific Lyophilized Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Lyophilized Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Lyophilized Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Lyophilized Drugs Market Size (2019-2030)
9.2 Latin America Lyophilized Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Lyophilized Drugs Market Size by Country (2019-2024)
9.4 Latin America Lyophilized Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lyophilized Drugs Market Size (2019-2030)
10.2 Middle East & Africa Lyophilized Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Lyophilized Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Lyophilized Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Lyophilized Drugs Introduction
11.1.4 Roche Revenue in Lyophilized Drugs Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Lyophilized Drugs Introduction
11.2.4 Amgen Revenue in Lyophilized Drugs Business (2019-2024)
11.2.5 Amgen Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Details
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Lyophilized Drugs Introduction
11.3.4 AbbVie Revenue in Lyophilized Drugs Business (2019-2024)
11.3.5 AbbVie Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Lyophilized Drugs Introduction
11.4.4 Sanofi Revenue in Lyophilized Drugs Business (2019-2024)
11.4.5 Sanofi Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Lyophilized Drugs Introduction
11.5.4 Johnson & Johnson Revenue in Lyophilized Drugs Business (2019-2024)
11.5.5 Johnson & Johnson Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Lyophilized Drugs Introduction
11.6.4 Pfizer Revenue in Lyophilized Drugs Business (2019-2024)
11.6.5 Pfizer Recent Development
11.7 Novo Nordisk
11.7.1 Novo Nordisk Company Details
11.7.2 Novo Nordisk Business Overview
11.7.3 Novo Nordisk Lyophilized Drugs Introduction
11.7.4 Novo Nordisk Revenue in Lyophilized Drugs Business (2019-2024)
11.7.5 Novo Nordisk Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Details
11.8.2 Eli Lilly Business Overview
11.8.3 Eli Lilly Lyophilized Drugs Introduction
11.8.4 Eli Lilly Revenue in Lyophilized Drugs Business (2019-2024)
11.8.5 Eli Lilly Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Lyophilized Drugs Introduction
11.9.4 Novartis Revenue in Lyophilized Drugs Business (2019-2024)
11.9.5 Novartis Recent Development
11.10 Merck
11.10.1 Merck Company Details
11.10.2 Merck Business Overview
11.10.3 Merck Lyophilized Drugs Introduction
11.10.4 Merck Revenue in Lyophilized Drugs Business (2019-2024)
11.10.5 Merck Recent Development
11.11 Biogen
11.11.1 Biogen Company Details
11.11.2 Biogen Business Overview
11.11.3 Biogen Lyophilized Drugs Introduction
11.11.4 Biogen Revenue in Lyophilized Drugs Business (2019-2024)
11.11.5 Biogen Recent Development
11.12 Celltrion
11.12.1 Celltrion Company Details
11.12.2 Celltrion Business Overview
11.12.3 Celltrion Lyophilized Drugs Introduction
11.12.4 Celltrion Revenue in Lyophilized Drugs Business (2019-2024)
11.12.5 Celltrion Recent Development
11.13 Sobi
11.13.1 Sobi Company Details
11.13.2 Sobi Business Overview
11.13.3 Sobi Lyophilized Drugs Introduction
11.13.4 Sobi Revenue in Lyophilized Drugs Business (2019-2024)
11.13.5 Sobi Recent Development
11.14 Merck & Co.
11.14.1 Merck & Co. Company Details
11.14.2 Merck & Co. Business Overview
11.14.3 Merck & Co. Lyophilized Drugs Introduction
11.14.4 Merck & Co. Revenue in Lyophilized Drugs Business (2019-2024)
11.14.5 Merck & Co. Recent Development
11.15 Bristol Myers Squibb
11.15.1 Bristol Myers Squibb Company Details
11.15.2 Bristol Myers Squibb Business Overview
11.15.3 Bristol Myers Squibb Lyophilized Drugs Introduction
11.15.4 Bristol Myers Squibb Revenue in Lyophilized Drugs Business (2019-2024)
11.15.5 Bristol Myers Squibb Recent Development
11.16 GlaxoSmithKline
11.16.1 GlaxoSmithKline Company Details
11.16.2 GlaxoSmithKline Business Overview
11.16.3 GlaxoSmithKline Lyophilized Drugs Introduction
11.16.4 GlaxoSmithKline Revenue in Lyophilized Drugs Business (2019-2024)
11.16.5 GlaxoSmithKline Recent Development
11.17 Takeda
11.17.1 Takeda Company Details
11.17.2 Takeda Business Overview
11.17.3 Takeda Lyophilized Drugs Introduction
11.17.4 Takeda Revenue in Lyophilized Drugs Business (2019-2024)
11.17.5 Takeda Recent Development
11.18 AstraZeneca
11.18.1 AstraZeneca Company Details
11.18.2 AstraZeneca Business Overview
11.18.3 AstraZeneca Lyophilized Drugs Introduction
11.18.4 AstraZeneca Revenue in Lyophilized Drugs Business (2019-2024)
11.18.5 AstraZeneca Recent Development
11.19 Bayer
11.19.1 Bayer Company Details
11.19.2 Bayer Business Overview
11.19.3 Bayer Lyophilized Drugs Introduction
11.19.4 Bayer Revenue in Lyophilized Drugs Business (2019-2024)
11.19.5 Bayer Recent Development
11.20 Astellas
11.20.1 Astellas Company Details
11.20.2 Astellas Business Overview
11.20.3 Astellas Lyophilized Drugs Introduction
11.20.4 Astellas Revenue in Lyophilized Drugs Business (2019-2024)
11.20.5 Astellas Recent Development
11.21 Gilead Sciences
11.21.1 Gilead Sciences Company Details
11.21.2 Gilead Sciences Business Overview
11.21.3 Gilead Sciences Lyophilized Drugs Introduction
11.21.4 Gilead Sciences Revenue in Lyophilized Drugs Business (2019-2024)
11.21.5 Gilead Sciences Recent Development
11.22 Teva
11.22.1 Teva Company Details
11.22.2 Teva Business Overview
11.22.3 Teva Lyophilized Drugs Introduction
11.22.4 Teva Revenue in Lyophilized Drugs Business (2019-2024)
11.22.5 Teva Recent Development
11.23 Boehringer Ingelheim
11.23.1 Boehringer Ingelheim Company Details
11.23.2 Boehringer Ingelheim Business Overview
11.23.3 Boehringer Ingelheim Lyophilized Drugs Introduction
11.23.4 Boehringer Ingelheim Revenue in Lyophilized Drugs Business (2019-2024)
11.23.5 Boehringer Ingelheim Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Lyophilized Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Single-Use Vials
 Table 3. Key Players of Prefilled Syringes
 Table 4. Key Players of Specialty Packaging
 Table 5. Global Lyophilized Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global Lyophilized Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 7. Global Lyophilized Drugs Market Size by Region (2019-2024) & (US$ Million)
 Table 8. Global Lyophilized Drugs Market Share by Region (2019-2024)
 Table 9. Global Lyophilized Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 10. Global Lyophilized Drugs Market Share by Region (2025-2030)
 Table 11. Lyophilized Drugs Market Trends
 Table 12. Lyophilized Drugs Market Drivers
 Table 13. Lyophilized Drugs Market Challenges
 Table 14. Lyophilized Drugs Market Restraints
 Table 15. Global Lyophilized Drugs Revenue by Players (2019-2024) & (US$ Million)
 Table 16. Global Lyophilized Drugs Market Share by Players (2019-2024)
 Table 17. Global Top Lyophilized Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lyophilized Drugs as of 2023)
 Table 18. Ranking of Global Top Lyophilized Drugs Companies by Revenue (US$ Million) in 2023
 Table 19. Global 5 Largest Players Market Share by Lyophilized Drugs Revenue (CR5 and HHI) & (2019-2024)
 Table 20. Global Key Players of Lyophilized Drugs, Headquarters and Area Served
 Table 21. Global Key Players of Lyophilized Drugs, Product and Application
 Table 22. Global Key Players of Lyophilized Drugs, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Lyophilized Drugs Market Size by Type (2019-2024) & (US$ Million)
 Table 25. Global Lyophilized Drugs Revenue Market Share by Type (2019-2024)
 Table 26. Global Lyophilized Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 27. Global Lyophilized Drugs Revenue Market Share by Type (2025-2030)
 Table 28. Global Lyophilized Drugs Market Size by Application (2019-2024) & (US$ Million)
 Table 29. Global Lyophilized Drugs Revenue Market Share by Application (2019-2024)
 Table 30. Global Lyophilized Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 31. Global Lyophilized Drugs Revenue Market Share by Application (2025-2030)
 Table 32. North America Lyophilized Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 33. North America Lyophilized Drugs Market Size by Country (2019-2024) & (US$ Million)
 Table 34. North America Lyophilized Drugs Market Size by Country (2025-2030) & (US$ Million)
 Table 35. Europe Lyophilized Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 36. Europe Lyophilized Drugs Market Size by Country (2019-2024) & (US$ Million)
 Table 37. Europe Lyophilized Drugs Market Size by Country (2025-2030) & (US$ Million)
 Table 38. Asia-Pacific Lyophilized Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 39. Asia-Pacific Lyophilized Drugs Market Size by Region (2019-2024) & (US$ Million)
 Table 40. Asia-Pacific Lyophilized Drugs Market Size by Region (2025-2030) & (US$ Million)
 Table 41. Latin America Lyophilized Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 42. Latin America Lyophilized Drugs Market Size by Country (2019-2024) & (US$ Million)
 Table 43. Latin America Lyophilized Drugs Market Size by Country (2025-2030) & (US$ Million)
 Table 44. Middle East & Africa Lyophilized Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 45. Middle East & Africa Lyophilized Drugs Market Size by Country (2019-2024) & (US$ Million)
 Table 46. Middle East & Africa Lyophilized Drugs Market Size by Country (2025-2030) & (US$ Million)
 Table 47. Roche Company Details
 Table 48. Roche Business Overview
 Table 49. Roche Lyophilized Drugs Product
 Table 50. Roche Revenue in Lyophilized Drugs Business (2019-2024) & (US$ Million)
 Table 51. Roche Recent Development
 Table 52. Amgen Company Details
 Table 53. Amgen Business Overview
 Table 54. Amgen Lyophilized Drugs Product
 Table 55. Amgen Revenue in Lyophilized Drugs Business (2019-2024) & (US$ Million)
 Table 56. Amgen Recent Development
 Table 57. AbbVie Company Details
 Table 58. AbbVie Business Overview
 Table 59. AbbVie Lyophilized Drugs Product
 Table 60. AbbVie Revenue in Lyophilized Drugs Business (2019-2024) & (US$ Million)
 Table 61. AbbVie Recent Development
 Table 62. Sanofi Company Details
 Table 63. Sanofi Business Overview
 Table 64. Sanofi Lyophilized Drugs Product
 Table 65. Sanofi Revenue in Lyophilized Drugs Business (2019-2024) & (US$ Million)
 Table 66. Sanofi Recent Development
 Table 67. Johnson & Johnson Company Details
 Table 68. Johnson & Johnson Business Overview
 Table 69. Johnson & Johnson Lyophilized Drugs Product
 Table 70. Johnson & Johnson Revenue in Lyophilized Drugs Business (2019-2024) & (US$ Million)
 Table 71. Johnson & Johnson Recent Development
 Table 72. Pfizer Company Details
 Table 73. Pfizer Business Overview
 Table 74. Pfizer Lyophilized Drugs Product
 Table 75. Pfizer Revenue in Lyophilized Drugs Business (2019-2024) & (US$ Million)
 Table 76. Pfizer Recent Development
 Table 77. Novo Nordisk Company Details
 Table 78. Novo Nordisk Business Overview
 Table 79. Novo Nordisk Lyophilized Drugs Product
 Table 80. Novo Nordisk Revenue in Lyophilized Drugs Business (2019-2024) & (US$ Million)
 Table 81. Novo Nordisk Recent Development
 Table 82. Eli Lilly Company Details
 Table 83. Eli Lilly Business Overview
 Table 84. Eli Lilly Lyophilized Drugs Product
 Table 85. Eli Lilly Revenue in Lyophilized Drugs Business (2019-2024) & (US$ Million)
 Table 86. Eli Lilly Recent Development
 Table 87. Novartis Company Details
 Table 88. Novartis Business Overview
 Table 89. Novartis Lyophilized Drugs Product
 Table 90. Novartis Revenue in Lyophilized Drugs Business (2019-2024) & (US$ Million)
 Table 91. Novartis Recent Development
 Table 92. Merck Company Details
 Table 93. Merck Business Overview
 Table 94. Merck Lyophilized Drugs Product
 Table 95. Merck Revenue in Lyophilized Drugs Business (2019-2024) & (US$ Million)
 Table 96. Merck Recent Development
 Table 97. Biogen Company Details
 Table 98. Biogen Business Overview
 Table 99. Biogen Lyophilized Drugs Product
 Table 100. Biogen Revenue in Lyophilized Drugs Business (2019-2024) & (US$ Million)
 Table 101. Biogen Recent Development
 Table 102. Celltrion Company Details
 Table 103. Celltrion Business Overview
 Table 104. Celltrion Lyophilized Drugs Product
 Table 105. Celltrion Revenue in Lyophilized Drugs Business (2019-2024) & (US$ Million)
 Table 106. Celltrion Recent Development
 Table 107. Sobi Company Details
 Table 108. Sobi Business Overview
 Table 109. Sobi Lyophilized Drugs Product
 Table 110. Sobi Revenue in Lyophilized Drugs Business (2019-2024) & (US$ Million)
 Table 111. Sobi Recent Development
 Table 112. Merck & Co. Company Details
 Table 113. Merck & Co. Business Overview
 Table 114. Merck & Co. Lyophilized Drugs Product
 Table 115. Merck & Co. Revenue in Lyophilized Drugs Business (2019-2024) & (US$ Million)
 Table 116. Merck & Co. Recent Development
 Table 117. Bristol Myers Squibb Company Details
 Table 118. Bristol Myers Squibb Business Overview
 Table 119. Bristol Myers Squibb Lyophilized Drugs Product
 Table 120. Bristol Myers Squibb Revenue in Lyophilized Drugs Business (2019-2024) & (US$ Million)
 Table 121. Bristol Myers Squibb Recent Development
 Table 122. GlaxoSmithKline Company Details
 Table 123. GlaxoSmithKline Business Overview
 Table 124. GlaxoSmithKline Lyophilized Drugs Product
 Table 125. GlaxoSmithKline Revenue in Lyophilized Drugs Business (2019-2024) & (US$ Million)
 Table 126. GlaxoSmithKline Recent Development
 Table 127. Takeda Company Details
 Table 128. Takeda Business Overview
 Table 129. Takeda Lyophilized Drugs Product
 Table 130. Takeda Revenue in Lyophilized Drugs Business (2019-2024) & (US$ Million)
 Table 131. Takeda Recent Development
 Table 132. AstraZeneca Company Details
 Table 133. AstraZeneca Business Overview
 Table 134. AstraZeneca Lyophilized Drugs Product
 Table 135. AstraZeneca Revenue in Lyophilized Drugs Business (2019-2024) & (US$ Million)
 Table 136. AstraZeneca Recent Development
 Table 137. Bayer Company Details
 Table 138. Bayer Business Overview
 Table 139. Bayer Lyophilized Drugs Product
 Table 140. Bayer Revenue in Lyophilized Drugs Business (2019-2024) & (US$ Million)
 Table 141. Bayer Recent Development
 Table 142. Astellas Company Details
 Table 143. Astellas Business Overview
 Table 144. Astellas Lyophilized Drugs Product
 Table 145. Astellas Revenue in Lyophilized Drugs Business (2019-2024) & (US$ Million)
 Table 146. Astellas Recent Development
 Table 147. Gilead Sciences Company Details
 Table 148. Gilead Sciences Business Overview
 Table 149. Gilead Sciences Lyophilized Drugs Product
 Table 150. Gilead Sciences Revenue in Lyophilized Drugs Business (2019-2024) & (US$ Million)
 Table 151. Gilead Sciences Recent Development
 Table 152. Teva Company Details
 Table 153. Teva Business Overview
 Table 154. Teva Lyophilized Drugs Product
 Table 155. Teva Revenue in Lyophilized Drugs Business (2019-2024) & (US$ Million)
 Table 156. Teva Recent Development
 Table 157. Boehringer Ingelheim Company Details
 Table 158. Boehringer Ingelheim Business Overview
 Table 159. Boehringer Ingelheim Lyophilized Drugs Product
 Table 160. Boehringer Ingelheim Revenue in Lyophilized Drugs Business (2019-2024) & (US$ Million)
 Table 161. Boehringer Ingelheim Recent Development
 Table 162. Research Programs/Design for This Report
 Table 163. Key Data Information from Secondary Sources
 Table 164. Key Data Information from Primary Sources
 Table 165. Authors List of This Report


List of Figures
 Figure 1. Lyophilized Drugs Picture
 Figure 2. Global Lyophilized Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Lyophilized Drugs Market Share by Type: 2023 VS 2030
 Figure 4. Single-Use Vials Features
 Figure 5. Prefilled Syringes Features
 Figure 6. Specialty Packaging Features
 Figure 7. Global Lyophilized Drugs Market Size by Application (2024-2030) & (US$ Million)
 Figure 8. Global Lyophilized Drugs Market Share by Application: 2023 VS 2030
 Figure 9. Hospitals Case Studies
 Figure 10. Ambulatory Surgical Centers Case Studies
 Figure 11. Specialty Clinics Case Studies
 Figure 12. Others Case Studies
 Figure 13. Lyophilized Drugs Report Years Considered
 Figure 14. Global Lyophilized Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 15. Global Lyophilized Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 16. Global Lyophilized Drugs Market Share by Region: 2023 VS 2030
 Figure 17. Global Lyophilized Drugs Market Share by Players in 2023
 Figure 18. Global Top Lyophilized Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lyophilized Drugs as of 2023)
 Figure 19. The Top 10 and 5 Players Market Share by Lyophilized Drugs Revenue in 2023
 Figure 20. North America Lyophilized Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 21. North America Lyophilized Drugs Market Share by Country (2019-2030)
 Figure 22. United States Lyophilized Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Canada Lyophilized Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. Europe Lyophilized Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. Europe Lyophilized Drugs Market Share by Country (2019-2030)
 Figure 26. Germany Lyophilized Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. France Lyophilized Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. U.K. Lyophilized Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Italy Lyophilized Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Russia Lyophilized Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Nordic Countries Lyophilized Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Asia-Pacific Lyophilized Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. Asia-Pacific Lyophilized Drugs Market Share by Region (2019-2030)
 Figure 34. China Lyophilized Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. Japan Lyophilized Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. South Korea Lyophilized Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. Southeast Asia Lyophilized Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. India Lyophilized Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Australia Lyophilized Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. Latin America Lyophilized Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Latin America Lyophilized Drugs Market Share by Country (2019-2030)
 Figure 42. Mexico Lyophilized Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Brazil Lyophilized Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Middle East & Africa Lyophilized Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Middle East & Africa Lyophilized Drugs Market Share by Country (2019-2030)
 Figure 46. Turkey Lyophilized Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. Saudi Arabia Lyophilized Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 48. UAE Lyophilized Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 49. Roche Revenue Growth Rate in Lyophilized Drugs Business (2019-2024)
 Figure 50. Amgen Revenue Growth Rate in Lyophilized Drugs Business (2019-2024)
 Figure 51. AbbVie Revenue Growth Rate in Lyophilized Drugs Business (2019-2024)
 Figure 52. Sanofi Revenue Growth Rate in Lyophilized Drugs Business (2019-2024)
 Figure 53. Johnson & Johnson Revenue Growth Rate in Lyophilized Drugs Business (2019-2024)
 Figure 54. Pfizer Revenue Growth Rate in Lyophilized Drugs Business (2019-2024)
 Figure 55. Novo Nordisk Revenue Growth Rate in Lyophilized Drugs Business (2019-2024)
 Figure 56. Eli Lilly Revenue Growth Rate in Lyophilized Drugs Business (2019-2024)
 Figure 57. Novartis Revenue Growth Rate in Lyophilized Drugs Business (2019-2024)
 Figure 58. Merck Revenue Growth Rate in Lyophilized Drugs Business (2019-2024)
 Figure 59. Biogen Revenue Growth Rate in Lyophilized Drugs Business (2019-2024)
 Figure 60. Celltrion Revenue Growth Rate in Lyophilized Drugs Business (2019-2024)
 Figure 61. Sobi Revenue Growth Rate in Lyophilized Drugs Business (2019-2024)
 Figure 62. Merck & Co. Revenue Growth Rate in Lyophilized Drugs Business (2019-2024)
 Figure 63. Bristol Myers Squibb Revenue Growth Rate in Lyophilized Drugs Business (2019-2024)
 Figure 64. GlaxoSmithKline Revenue Growth Rate in Lyophilized Drugs Business (2019-2024)
 Figure 65. Takeda Revenue Growth Rate in Lyophilized Drugs Business (2019-2024)
 Figure 66. AstraZeneca Revenue Growth Rate in Lyophilized Drugs Business (2019-2024)
 Figure 67. Bayer Revenue Growth Rate in Lyophilized Drugs Business (2019-2024)
 Figure 68. Astellas Revenue Growth Rate in Lyophilized Drugs Business (2019-2024)
 Figure 69. Gilead Sciences Revenue Growth Rate in Lyophilized Drugs Business (2019-2024)
 Figure 70. Teva Revenue Growth Rate in Lyophilized Drugs Business (2019-2024)
 Figure 71. Boehringer Ingelheim Revenue Growth Rate in Lyophilized Drugs Business (2019-2024)
 Figure 72. Bottom-up and Top-down Approaches for This Report
 Figure 73. Data Triangulation
 Figure 74. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network